Pedro Iván Arias-Vázquez, Russell Arcila-Novelo, Mauro Nicolás Guzzardo, Duilio Román Guzzardo, Miguel Ángel Nazul Ake-Montiel, André Sulub-Herrera
{"title":"Subcutaneous injections of dextrose in musculoskeletal pain, a potential therapeutic intervention: scoping review.","authors":"Pedro Iván Arias-Vázquez, Russell Arcila-Novelo, Mauro Nicolás Guzzardo, Duilio Román Guzzardo, Miguel Ángel Nazul Ake-Montiel, André Sulub-Herrera","doi":"10.1080/17581869.2024.2442898","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aims of this review were to identify and to analyze the clinical studies that used subcutaneous injections of dextrose for treating musculoskeletal pain, in order to establish an overview.</p><p><strong>Methods: </strong>A systematic search was carried out in scientific databases including Web of Science, Cochrane Central Register of Controlled Trials, PUBMED and other sources, up until March 2024. We included clinical studies that used subcutaneous injections of dextrose in the treatment of individuals with musculoskeletal pain associated with tendinopathies, enthesopathy, osteoarthritis, ligament sprains, muscle strains or bursitis of various locations.</p><p><strong>Results: </strong>Twenty studies that met the criteria were included in this review; of those, 13 were randomized clinical trials, one non-randomized comparative study and six were case series studies, comprising a total of 1226 patients. In all included studies, efficacy in pain reduction was reported in the groups treated with dextrose when comparing evaluations at baseline, short term and medium term.</p><p><strong>Conclusions: </strong>Subcutaneous injections of dextrose could be a beneficial treatment for reducing musculoskeletal pain; however, factors such as the high heterogeneity in the treatment schemes, uncertainty in the mechanisms of action and the level of evidence found, indicate that this technique is still under development.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":" ","pages":"653-663"},"PeriodicalIF":1.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703374/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17581869.2024.2442898","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The aims of this review were to identify and to analyze the clinical studies that used subcutaneous injections of dextrose for treating musculoskeletal pain, in order to establish an overview.
Methods: A systematic search was carried out in scientific databases including Web of Science, Cochrane Central Register of Controlled Trials, PUBMED and other sources, up until March 2024. We included clinical studies that used subcutaneous injections of dextrose in the treatment of individuals with musculoskeletal pain associated with tendinopathies, enthesopathy, osteoarthritis, ligament sprains, muscle strains or bursitis of various locations.
Results: Twenty studies that met the criteria were included in this review; of those, 13 were randomized clinical trials, one non-randomized comparative study and six were case series studies, comprising a total of 1226 patients. In all included studies, efficacy in pain reduction was reported in the groups treated with dextrose when comparing evaluations at baseline, short term and medium term.
Conclusions: Subcutaneous injections of dextrose could be a beneficial treatment for reducing musculoskeletal pain; however, factors such as the high heterogeneity in the treatment schemes, uncertainty in the mechanisms of action and the level of evidence found, indicate that this technique is still under development.
背景:本综述的目的是识别和分析使用皮下注射葡萄糖治疗肌肉骨骼疼痛的临床研究,以建立一个概述。方法:系统检索截至2024年3月的科学数据库,包括Web of Science、Cochrane Central Register of Controlled Trials、PUBMED等。我们纳入了使用葡萄糖皮下注射治疗与肌腱病、骨髓炎、骨关节炎、韧带扭伤、肌肉拉伤或不同部位滑囊炎相关的肌肉骨骼疼痛的临床研究。结果:本综述纳入了20项符合标准的研究;其中13项为随机临床试验,1项为非随机比较研究,6项为病例系列研究,共纳入1226例患者。在所有纳入的研究中,在比较基线、短期和中期评估时,用葡萄糖治疗的组报告了疼痛减轻的疗效。结论:皮下注射葡萄糖可有效减轻骨骼肌疼痛;然而,诸如治疗方案的高度异质性、作用机制的不确定性以及所发现的证据水平等因素表明,该技术仍处于发展阶段。